Last reviewed · How we verify
NCT03120169
Effects of Treadmill Versus Cycling Endurance Training in Patients With COPD
NA trial testing treadmill endurance training in Chronic Obstructive Pulmonary Disease in 30 participants. Completed in 27 November 2017.
27 November 2017
Quick facts
| Lead sponsor | Schön Klinik Berchtesgadener Land |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 30 March 2017 |
| Primary completion | 27 November 2017 |
| Estimated completion | 27 November 2017 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- treadmill endurance training
- cycling endurance training
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Sponsor
Schön Klinik Berchtesgadener Land
Who can join
Adults 50 to 80, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim of this study is to investigate the effects of treadmill versus cycling endurance training on Balance, gait performance and exercise capacity in patients with severe chronic obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized into one of two intervention groups. Walking intensity in the treadmill group will be set at 80 percent of the average speed of the 6-minute walking test. The cycling group will exercise at an intensity of 60 percent according to an Initial incremental cycling test. Patients will perform 5 to 6 training sessions per week. The total exercise duration will be progressively increased from 10 to 30 minutes. Walking or cycling intensity will also be progressively increased if perceived exertion during exercise is rated below 3 on the modified 10-point Borg scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03120169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other Schön Klinik Berchtesgadener Land trials
Trials by the same sponsor.
- NCT07013903 — Effects of Hydrotherapy During Post-COVID-19 Rehabilitation · NA · recruiting
- NCT06545851 — Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training · NA · recruiting
- NCT05172206 — Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a Randomized Controlled Trial · NA · completed
- NCT05124548 — Sleep Characteristics in Post-COVID-19 Patients · completed
- NCT05126511 — Effects of Cranial Electrotherapy Stimulation on Anxiety of Patients After COVID-19 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03120169 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Schön Klinik Berchtesgadener Land
- Last refreshed: 15 February 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03120169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing